Semacare
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Semacare - overview
Established
2019
Location
Shenzhen, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Established in 2019 and based in Shenzhen, China, Semacare is a medical technology company that focuses on early detection of cardiovascular diseases through a monitoring and recovering system. In July 2020, the firm closed a series A funding. The company's predecessor was Sumika Medical. As of 2024, it acquires ISO9001 certification.
The company's main products include MetaCor, Homer and ZhixinPie™, etc. MetaCor provides cardiac data collection and other services based on the machine learning algorithm MetaAI. The company's products are used in clinical and remote ECG diagnosis and monitoring fields. The company’s revenue is generated by providing MetaCor, Homer and ZhixinPie™, etc.
Current Investors
Initial Science Value Investment, Leaguer Group
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Medical Software
Website
www.semacare.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Semacare - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A | Completed | Semacare | - | ||||||||
| Unspecified Round | Completed | Semacare | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.